🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The drug nimorazole belongs to a class of chemicals known as 5-nitroimidazo...
Status
Unknown
Location
Royal Brisbane And Women's Hospital
Start Date
2014-07-25
Trial ID
NCT01880359
Treatments Being Tested
This trial aims to evaluate the efficacy and safety between radiotherapy al...
Status
Unknown
Location
Department of Radiation Oncology, Tianjin Medical University Cancer Hospital
Start Date
2012-01
Trial ID
NCT01745445
Treatments Being Tested
This phase I trial studies the side effects and the best dose of WEE1 inhib...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-07-22
Trial ID
NCT02508246
Randomized comparison of neoadjuvant chemotherapy followed by radical hyste...
Status
Unknown
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02422563
Treatments Being Tested
This is a phase 2, single-arm clinical trial, with the purpose to evaluate ...
Status
Completed
Location
Chongqing University Cancer Hospital
Start Date
2022-01-01
Trial ID
NCT05213884
Treatments Being Tested
The main purpose of this study is to investigate the safety of prexasertib ...
Status
Completed
Location
University of Alabama at Birmingham Medical Center
Start Date
2016-02-24
Trial ID
NCT02555644
Treatments Being Tested
This study is conducted to evaluate efficacy and safety of neoadjuvant chem...
Status
Unknown
Location
Alexey Tryakin
Start Date
2017-07-10
Trial ID
NCT03579004
Treatments Being Tested
To compare the differential influence of 1st line doublet chemotherapy cont...
Status
Completed
Location
Chang Gung Memorial Hospital
Start Date
2010-01
Trial ID
NCT01204307
Treatments Being Tested
Prevention of critical weight loss. In patients with Squamous Cell Carcinom...
Status
Terminated
Location
Landeskrankenhaus Feldkirch
Start Date
2017-02-03
Trial ID
NCT02236936
Nimotuzumab is an IgG1 humanized monoclonal antibody that recognized an epi...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2009-10
Trial ID
NCT01074021
Treatments Being Tested